Bonus Biogroup (Israel) Today
| BONS Stock | ILS 10.80 0.10 0.93% |
Performance0 of 100
| Odds Of DistressLess than 21
|
Bonus Biogroup is trading at 10.80 as of the 2nd of December 2024, a 0.93% increase since the beginning of the trading day. The stock's open price was 10.7. Bonus Biogroup has about a 21 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Bonus Biogroup are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of April 2024 and ending today, the 2nd of December 2024. Click here to learn more.
Bonus BioGroup Ltd., a biotechnology company, develops technology solutions to generate tissue-regenerating bone grafts. Bonus BioGroup Ltd., formerly known as Oceana Advanced Industries Ltd., was founded in 1981 and is based in Haifa, Israel. BONUS BIOGROUP is traded on Tel Aviv Stock Exchange in Israel.. The company has 1.17 B outstanding shares. More on Bonus Biogroup
Moving together with Bonus Stock
Moving against Bonus Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Bonus Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Bonus Biogroup's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Bonus Biogroup or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Shai Meretzki |
| Business Concentration | Health Care, Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care (View all Sectors) |
Bonus Biogroup (BONS) is traded on Tel Aviv Stock Exchange in Israel and employs 13 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 223.15 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bonus Biogroup's market, we take the total number of its shares issued and multiply it by Bonus Biogroup's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Bonus Biogroup operates under Biotechnology sector and is part of Health Care industry. The entity has 1.17 B outstanding shares.
Bonus Biogroup has accumulated about 3.6 M in cash with (39.84 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Bonus Biogroup Probability Of Bankruptcy
Ownership AllocationBonus Biogroup holds a total of 1.17 Billion outstanding shares. Bonus Biogroup retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Bonus Ownership Details
Bonus Biogroup Risk Profiles
Although Bonus Biogroup's alpha and beta are two of the key measurements used to evaluate Bonus Biogroup's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.52 | |||
| Standard Deviation | 2.03 | |||
| Variance | 4.11 | |||
| Risk Adjusted Performance | (0.18) |
Bonus Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Bonus Biogroup without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
Other Information on Investing in Bonus Stock
Bonus Biogroup financial ratios help investors to determine whether Bonus Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bonus with respect to the benefits of owning Bonus Biogroup security.